Illumina Obtains More Than 55 Gb from GA; Expects Large NIH Stimulus Awards for Sequencing

The company reported $162 million in total revenue for the second quarter, a 15 percent increase over the prior-year quarter that company officials attributed to "significant" growth in sales of sequencing products.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.